Anxiety and Related Sleep Disorders - Ireland

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$33.34m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.65%, resulting in a market volume of US$34.43m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$74.53 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Ireland has seen significant growth in recent years, driven by increasing awareness and diagnosis of these conditions, as well as a growing demand for effective treatment options.

Customer preferences: Customers in Ireland are increasingly seeking out treatments for anxiety and related sleep disorders, as they become more aware of the impact these conditions can have on their overall health and well-being. They are looking for solutions that are safe, effective, and convenient to use. Many customers are also interested in natural and holistic remedies, as they prioritize a more holistic approach to their health.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Ireland is the growing popularity of non-pharmaceutical treatments. Many customers are turning to alternative therapies such as cognitive behavioral therapy (CBT) and mindfulness-based stress reduction (MBSR) to manage their symptoms. These therapies offer a more holistic approach to treatment, focusing on addressing the underlying causes of anxiety and sleep disorders rather than just treating the symptoms. Another trend in the market is the increasing availability of digital health solutions. With the rise of smartphones and wearable devices, customers now have access to a wide range of mobile apps and online platforms that offer tools and resources for managing anxiety and sleep disorders. These digital solutions provide convenience and accessibility, allowing customers to access support and treatment options from the comfort of their own homes.

Local special circumstances: In Ireland, there is a strong cultural emphasis on mental health and well-being. The country has made significant progress in reducing the stigma surrounding mental health issues, leading to increased awareness and acceptance of anxiety and related sleep disorders. This cultural shift has contributed to a growing demand for treatment options and support services in the country.

Underlying macroeconomic factors: The growing Anxiety and Related Sleep Disorders market in Ireland is also influenced by several underlying macroeconomic factors. The country has experienced a period of economic growth in recent years, resulting in increased disposable income and healthcare spending. This has allowed more customers to seek out and afford treatment options for anxiety and sleep disorders. Additionally, the aging population in Ireland is also contributing to the growth of the market, as older adults are more likely to experience these conditions and seek treatment. In conclusion, the Anxiety and Related Sleep Disorders market in Ireland is experiencing significant growth, driven by increasing awareness and diagnosis of these conditions, as well as a growing demand for safe and effective treatment options. Customers in Ireland are seeking out non-pharmaceutical and digital health solutions, while also prioritizing a holistic approach to their health. The local cultural emphasis on mental health and well-being, along with underlying macroeconomic factors such as economic growth and an aging population, are further contributing to the development of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.